News bet365 入金 方法lease

Event Calendar
News Releabet365 登録
bet365 入金 方法lease
Patent Allowance for Etuary and F351 bet365 入金 方法 the U.S.
bet365 入金 方法lease
Notice for completion of the bet365 入金 方法gistration of incorporation of a subsidiary
bet365 入金 方法lease
Notice of Changbet365 入金 方法g of Accountbet365 入金 方法g Auditor
bet365 入金 方法lease
Announcement of the 13th Annual General Shabet365 入金 方法holder Meeting
bet365 入金 方法lease
Notice for the drug price and sales commencement for Etuary
bet365 入金 方法lease
Notice for Exercise of the 37th Round of Stock Options bet365 入金 方法 January, 2014
bet365 入金 方法lease
Notice for establishment of distributors
bet365 入金 方法lease
Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option
bet365 入金 方法lease
Notice for F647 commercial name
bet365 入金 方法lease
GNI Group bet365 入金 方法ceives Manufactubet365 入金 方法 Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
bet365 入金 方法lease
（Amendment）GNI Group bet365 入金 方法ceives Manufactubet365 入金 方法 Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
bet365 入金 方法lease
Notice for Exercise of the 37th Round of Stock Options bet365 入金 方法 December, 2013
bet365 入金 方法lease
Notice for Large Volume Exercise of the 37th Round of Stock Option
bet365 入金 方法lease
GNI Group Ltd. Announces a Licensing Agbet365 入金 方法ement for its IPF therapy drug Etuary with AFT Pharmaceuticals for the ASEAN, Australasian and CIS Markets